Urgent Information Regarding Drug RECALL – Department of Drug Administration

Urgent Information Regarding Drug RECALL - Department of Drug Administration
Sharing is Caring !!

Urgent Information Regarding Drug RECALL – Department of Drug Administration

Samples of medicines collected during market monitoring from  Department of Drug Administration are tested and manufactured by the manufacturers as per the specifications Batch no. The drug was found to be of low quality, Recall the sale and distribution as per Section 14 of the Drugs Act 2035 and withdraw it from the market immediately & This information has been published for the information of the official importers of the industry and their official representatives to submit the details to the Departmet of Drug Administration. Also, all concerned are requested not to recommend, sell, distribute and even use the drug.

Medicine:-  BEN-A (Albendazole tablet USP) manufactured by ACME Laboratories.

Urgent Information Regarding Drug RECALL - Department of Drug Administration
                           Urgent Information Regarding Drug RECALL – Department of Drug Administration

For more Detail Visit :- Department of Drug Administration



 

Sharing is Caring !!

Leave a Reply

Your email address will not be published. Required fields are marked *

Department of Drug Administration Notice Regarding Misinformation of Covid-19 Department…
Cresta Posts Box by CP
error:
X